Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Declines By 15.6%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 13,000 shares, a decline of 15.6% from the November 15th total of 15,400 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is currently 0.6 days.

Cardio Diagnostics Trading Up 10.2 %

Shares of Cardio Diagnostics stock traded up $0.01 during trading hours on Monday, hitting $0.12. 175,333 shares of the company’s stock traded hands, compared to its average volume of 27,764. The company has a fifty day simple moving average of $0.04 and a 200-day simple moving average of $0.04. Cardio Diagnostics has a 12-month low of $0.02 and a 12-month high of $0.28.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.